Study on calming severe agitation in psychiatric emergency rooms
Part of Brain & nervous system clinical trials.
This trial tests two different medications to quickly calm severe agitation in people admitted to a psychiatric emergency room. You may be able to join if you are extremely agitated and need urgent medication to help you settle down.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are currently in a psychiatric emergency room or inpatient unit and need medication for severe agitation.
- You have a total score of at least 14 on a scale that measures agitation, with at least one symptom rated as severe.
- You are able to give your consent before the emergency treatment starts.
- You are not involuntarily admitted under the Danish Mental Health Act.
- If you are a female and could become pregnant, you must have a negative pregnancy test and use reliable birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if combining two medicines, esketamine and dexmedetomidine, is better than dexmedetomidine alone for calming severe confusion and agitation in ICU patients who need breathing support through a mask or nasal tubes. It aims to find a safer, more effective way to help patients rest and recover.
This trial tests two medicines, haloperidol and dexmedetomidine, to see which one works better for calming confusion and agitation in ICU patients who have a traumatic brain injury and are on a breathing machine. If you qualify, the study may help your doctors choose the best treatment for you.
This trial tests a sedative drug (dexmedetomidine) to see if it helps calm agitation in patients with moderate or severe traumatic brain injury who are on a breathing machine in the ICU. The goal is to improve comfort and recovery.
This trial tests whether dexmedetomidine can help calm agitation caused by delirium in adults receiving palliative (comfort-focused) care. It may help reduce restlessness and distress when standard approaches may not be enough.
This early-phase trial compares two calming medicines to help critically ill, agitated patients come off the breathing machine earlier and more safely. Your participation would help doctors learn which medicine works better for agitation during the weaning process.
This study tests a multi-step program to prevent and lessen agitation in ICU patients, with the goal of reducing the need for physical restraints. It also aims to improve comfort and safety during a longer ICU stay.
Hear when a new Agitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.